Jessica Moss - Department of Medicine, University of Kentucky

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Analysis of Extracellular Vesicle Protein Profiles to Predict Treatment Response in a Phase II Clinical Trial with Cabozantinib and Pembrolizumab for Refractory Metastatic Pancreatic Cancer

Hannah G. McDonald, Anna Reagan,Reema A. Patel,Jessica Moss,Snigdha Nutalapati,Michael J. Cavnar,Prakash K. Pandalai,Mautin Barry-Hundeyin,Teresa Cassel,Andrew Lane,Richard Higashi,Teresa Fan,Joseph Kim

ANNALS OF SURGICAL ONCOLOGY（2024）

引用0浏览0引用

ASO Visual Abstract: Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using the Codman Vascular Catheter with the Medtronic Synchromed II Pump for Intrahepatic Cancers

Hannah G. McDonald, Omar A. Zaki,Matt J. Wright,Rani Jayswal,Heidi Weiss,Rashmi T. Nair,Halemane Ganesh, Scott Ellis,Jill M. Kolesar,Jessica Moss,Mautin Barry-Hundeyin,Prakash K. Pandalai,Joseph Kim,Reema A. Patel,Michael J. Cavnar

ANNALS OF SURGICAL ONCOLOGY（2024）

引用0浏览0WOS引用

Development of a Novel Protocol for Germline Testing in Pancreatic Cancer

Hannah G. McDonald, Andrew Kennedy,Angelica L. Solomon, Chelsey M. Williams, Anna M. Reagan, Emily Cassim,Megan Harper,Erin Burke, Terra Armstrong, Michael Gosky,Michael Cavnar,Prakash K. Pandalai,Mautin Barry-Hundeyin,Reema Patel,Snigdha Nutalapati,Jessica Moss,Pamela C. Hull,Jill Kolesar,Justine C. Pickarski,Joseph Kim

ANNALS OF SURGICAL ONCOLOGYno. 12 (2024): 7705-7712

引用0浏览0WOS引用

Abstract PO3-10-10: Are We Adequately Integrating Patient Reported Outcomes in Breast Cancer Clinical Trials

Yadav Rina,Zhengyan Huang,Jessica Moss,Garima Gupta

Cancer researchno. 9_Supplement (2024): PO3-10

引用0浏览0引用

Abstract PO3-10-10: Are we adequately integrating patient reported outcomes in breast cancer clinical trials

Yadav Rina, Zhengyan Huang,Jessica Moss, Garima Gupta

Cancer Researchno. 9_Supplement (2024): PO3-10

引用0浏览0引用

Abstract PS17-06: A phase I trial of the PI3K inhibitor (PI3Ki) copanlisib and fulvestrant in combination with continuous or intermittent abemaciclib in patients with estrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast cancer

Cynthia Ma,Jingqin Luo,Jessica Moss,Maryann Kwa,Ritesh Parajuli,Katia Khoury,Emily Douglas,Ashley Frith,Caron Rigden,Foluso Ademuyiwa,Shana Thomas,Brittney Haas,Gerburg Wulf,Claire Dees,Rabih Said

Cancer Researchno. 9_Supplement (2024): PS17-06

引用0浏览0引用

Validation of a Novel Web-Based Application for Hepatic Arterial Infusion Floxuridine Dosing

Carleton Scott Ellis, Snigdha Nutalapati,Jessica Jane Moss, Mautin S. Barry-Hundeyin,Prakash Pandalai,Joseph Kim,Reema Anil Patel,Michael J. Cavnar

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): 15-15

引用0浏览0引用

Ki-67 Testing in Breast Cancer: Assessing Variability with Scoring Methods and Specimen Types and the Potential Subsequent Impact on Therapy Eligibility

Therese Bocklage,Virgilius Cornea,Caylin Hickey,Justin Miller,Jessica Moss, Mara Chambers,S. Emily Bachert

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGYno. 3 (2024): 119-124

引用0浏览0WOS引用

Ki-67 Expression in Invasive carcinomas of the Breast: Does Specimen Type and Manual vs Automated Counting Impact Abemaciclib Eligibility

Therese Bocklage,Virgilius Cornea,Jessica Moss,Derek Allison,Robert McDonald,Sara Bachert

LABORATORY INVESTIGATIONno. 3 (2023): S104-S105

引用0浏览0引用

Ki-67 Expression in Invasive Carcinomas of the Breast: Does Scoring Method Impact Abemaciclib Eligibility

Therese Bocklage,Virgilius Cornea, Mara Chambers,Jessica Moss,Sara Bachert

LABORATORY INVESTIGATIONno. 3 (2023): S105-S106

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn